SPP1 is required for maintaining mesenchymal cell fate in pancreatic cancer
Huafu Li(Institute of Cancer Research), Axel Behrens(King's College London), Ian Evans(Institute of Cancer Research), E. Josue Ruiz(Institute of Cancer Research), Changhua Zhang(Sun Yat-sen University), Jian Ma(Sun Yat-sen University), Anguraj Sadanandam(Institute of Cancer Research), Shao‐Zhen Lin(Centre National de la Recherche Scientifique), Tingzhuang Yi(Affiliated Hospital of Youjiang Medical University for Nationalities), May Zaw Thin(Institute of Cancer Research), Hari PS(Institute of Cancer Research), Linxiang Lan(Sun Yat-sen University), Hengxing Chen(Sun Yat-sen University), Yulong He(Sun Yat-sen University), Chunming Wang(Sun Yat-sen University), Rongjie Cheng(State Key Laboratory of Pharmaceutical Biotechnology), Mark Allen(Royal Marsden NHS Foundation Trust), Li Tran(Institute of Cancer Research), Jessica K. Nelson(Centre National de la Recherche Scientifique), Naomi Guppy(Breast Cancer Now)
Cited by 20
Related Papers
The prognostic significance of the prognostic nutritional index in cancer: a systematic review and meta-analysis
|Journal of Cancer Research and Clinical Oncology|2014|414
Inter‐ and intra‐tumoural heterogeneity in cancer‐associated fibroblasts of human pancreatic ductal adenocarcinoma
|The Journal of Pathology|2018|284
YAP1 and TAZ Control Pancreatic Cancer Initiation in Mice by Direct Up-regulation of JAK–STAT3 Signaling
|Gastroenterology|2016|223